Our data demonstrate that both DUSP5 and DUSP6 perform at least partially non-redundant functions in restraining the early stages of murine pancreatic cancer development driven by oncogenic mutant KRASG12D. The gene discussed is DUSP5; the disease is familial pancreatic carcinoma.